As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  8/3/17  Cardinal Health Inc.              NO ACT       7/3/17    1:2K                                     SEC #7                   
  8/3/17  Access Investments, Inc.          X-17A-5     5/31/17    1:2K                                     SEC #7                   
  8/3/17‡ Ichor Holdings, Ltd.              EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Immune Pharmaceuticals Inc.       EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Coeur Mining, Inc.                EFFECT       8/3/17    1:9K                                     SEC #5                   
          Coeur Alaska, Inc.
          Coeur Capital, Inc.
          Coeur Explorations, Inc.
          Coeur Rochester, Inc.
          Coeur South America Corp.
          Golden Reward Mining Co. Ltd. Partnership
          Wharf Gold Mines Inc.
          Wharf Resources (U.S.A.), Inc.
          Wharf Resources Management Inc.
          Wharf Reward Mines Inc.
  8/3/17‡ Senomyx Inc.                      EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Rosetta Genomics Ltd.             EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Sow Good Inc.                     EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Trilogy Int’l Partners Inc.       EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Ur-Energy Inc.                    EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Iovance Biotherapeutics, Inc.     EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Iovance Biotherapeutics, Inc.     EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Rekor Systems, Inc.               EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Iovance Biotherapeutics, Inc.     EFFECT       8/3/17    1:2K                                     SEC #5                   
  8/3/17‡ Corporate Capital Trust, Inc.     DEFA14A      8/3/17    1:277K                                   Quality EDGAR So… LLC/FA 
  8/3/17  Legg Mason Global Asset Mgmt Tr   497K         8/3/17    1:171K                                   Donnelley … Solutions/FA 
          → Martin Currie Emerging Markets Fund
  8/3/17  Legg Mason Global Asset Mgmt Tr   497          8/3/17    1:171K                                   Donnelley … Solutions/FA 
          → Martin Currie Emerging Markets Fund
  8/3/17  Legg Mason Global Asset Mgmt Tr   497K         8/3/17    1:18K                                    Donnelley … Solutions/FA 
          → BrandywineGLOBAL – Alternative Credit Fund
  8/3/17  Legg Mason Global Asset Mgmt Tr   497          8/3/17    1:18K                                    Donnelley … Solutions/FA 
          → BrandywineGLOBAL – Alternative Credit Fund
  8/3/17  GPS Funds II                      497J         8/3/17    1:12K                                    US Bancorp Fund Svcs LLC 
          → GuideMark® Opportunistic Fixed Income Fund
          → GuidePath® Absolute Return Allocation Fund
          → GuidePath® Conservative Allocation Fund
          → GuidePath® Flexible Income Allocation Fund
          → GuidePath® Growth Allocation Fund
          → GuidePath® Managed Futures Strategy Fund
          → GuidePath® Multi-Asset Income Allocation Fund
          → GuidePath® Tactical Allocation Fund

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	497	Definitive Material.
	497J	Certification of No Change in Definitive Material.
	497K	Prospectus – Open-End Investment Company – Summary.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	EFFECT	SEC Notice of Effectiveness.
	NO ACT	SEC No-Action Letter re: a Shareholder Proposal.
	X-17A-5	Annual Financial Report [ a.k.a. FOCUS Report ] by a Broker or Dealer — Form X-17A-5.
→	Fund / Series:  Fund or Series of this Filer with a Class or Contract that this Filing pertains to.